MELISSA RAMIREZ: Open Payments
NPI 1750610184 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,621 in 94 payments from 17 companies in 2025. Trend: 2023 $1,656 · 2024 $1,897 · 2025 $1,621
Food & beverage: $1,621
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 10 | $254 |
| ABBVIE INC. | 19 | $243 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $206 |
| Janssen Pharmaceuticals, Inc | 4 | $203 |
| Otsuka America Pharmaceutical, Inc. | 16 | $147 |
| Vanda Pharmaceuticals Inc. | 6 | $104 |
| Supernus Pharmaceuticals, Inc. | 3 | $72 |
| Vertical Pharmaceuticals, LLC | 2 | $72 |
| Lundbeck LLC | 3 | $62 |
| Tris Pharma Inc | 3 | $44 |
Products named: Azstarys, VRAYLAR, CAPLYTA, SPRAVATO, REXULTI, FANAPT, Qelbree, Relexxii.
Industry payments across AZ — which companies pay providers there.
